1.Effect of thyroid hormone on the alcohol dehydrogenase activities in rat tissues.
Dong Sun KIM ; Chang Beom LEE ; Yong Soo PARK ; You Hern AHN ; Tae Wha KIM ; Choon Suhk KEE ; Ju Seop KANG ; Ae Son OM
Journal of Korean Medical Science 2001;16(3):313-316
The effects of thyroid hormone on hepatic and gastric alcohol dehydrogenase (ADH) activities (nM of NADH/min/mg of cytosolic protein) have been investigated in male Sprague Dawley rats treated with thyroxine (1 mg/kg, po) for 14 days. Whereas hepatic ADH activity in thyroxine-treated rats decreased by 61.3% of control rats (26.4 vs 43.2, p<0.001), gastric ADH activity increased by 262.9% of control rats (4.9 vs 1.9, p<0.001). As for the activities of the lung and kidney, thyroxine treatment did not produce any statistically significant changes. These data suggest that thyrotoxicosis causes a decrease of hepatic alcohol metabolism, and that the increase of gastric ADH activity in thyrotoxic rats can partly restore the first-pass metabolism of ethanol.
Alcohol Dehydrogenase/*metabolism
;
Animal
;
Gastric Mucosa/enzymology
;
Kidney/enzymology
;
Liver/drug effects/*enzymology
;
Lung/enzymology
;
Male
;
Rats
;
Rats, Sprague-Dawley
;
Stomach/drug effects/*enzymology
;
Thyrotoxicosis/chemically induced/metabolism
;
Thyroxine/administration & dosage/*metabolism/pharmacology
2.The expression and activity of caspase-8 in the process of vitamin E succinate-induced apoptosis in human gastric carcinoma SGC-7901 cells.
Yao LI ; Kun WU ; Wei-ping YU
Chinese Journal of Preventive Medicine 2003;37(2):112-114
OBJECTIVETo investigate the role of caspase-8 in vitamin E succinate (VES)-induced apoptosis in human gastric carcinoma cells.
METHODSThe expression and activity of caspase-8 were measured by the Western Blot method with fluorescence and DAPI staining.
RESULTSVES treatment induced the expression and activity of caspase-8 in a dose-dependent manner; the apoptosis ratio induced by VES was significantly decreased in SGC-7901 cells treated with caspase-8 inhibitor.
CONCLUSIONCaspase-8 plays an important role in SGC-7901 cell apoptosis induced by VES.
Apoptosis ; drug effects ; Caspase 8 ; Caspases ; metabolism ; physiology ; Dose-Response Relationship, Drug ; Humans ; Stomach Neoplasms ; enzymology ; pathology ; Tocopherols ; Tumor Cells, Cultured ; Vitamin E ; analogs & derivatives ; pharmacology
3.Hepatocyte Growth Factor/c-Met Signaling in Regulating Urokinase Plasminogen Activator in Human Stomach Cancer: A Potential Therapeutic Target for Human Stomach Cancer.
Kyung Hee LEE ; Eun Young CHOI ; Myung Soo HYUN ; Byung Ik JANG ; Tae Nyeun KIM ; Sang Woon KIM ; Sun Kyo SONG ; Jung Hye KIM ; Jae Ryong KIM
The Korean Journal of Internal Medicine 2006;21(1):20-27
BACKGROUND: Up-regulation of the hepatocyte growth factor (HGF), its transmembrane tyrosine kinase receptor (c-Met), and urokinase type plasminogen activator (uPA), is associated with the development and metastasis of various types of cancers. However, the mechanisms by which HGF/c-Met signaling mediates cancer progression and metastasis are unclear. METHODS: We investigated the roles of HGF/c-Met in tumor progression and metastasis in NUGC-3 and MKN-28 stomach cancer cell lines. RESULTS: Treatment with HGF increased c-Met phosphorylation in a dose-dependent manner, as well as increasing cell proliferation. HGF treatment also increased the protein level and the activity of uPA in NUGC-3 and MKN-28 cells. A monoclonal antibody against human uPA receptor (uPAR), mAb 3936, inhibited HGF-mediated tumor cell invasion in a dose-dependent manner. Down-regulation of uPA using uPA-shRNA induced a decrease in in vitro cell invasion in NUGC-3 cells. CONCLUSIONS: These results suggest that NUGC-3 and MKN-28 cells express functional c-Met, which may provide a therapeutic target for interfering with metastases of cancer cells by inhibiting uPA and uPAR-mediated proteolysis.
Urinary Plasminogen Activator/antagonists & inhibitors/*metabolism
;
Stomach Neoplasms/drug therapy/*enzymology
;
Signal Transduction/*drug effects
;
Receptors, Growth Factor/*drug effects
;
Receptor Protein-Tyrosine Kinases/*drug effects
;
Proto-Oncogene Proteins c-met/*drug effects
;
Neoplasm Metastasis
;
Humans
;
Hepatocyte Growth Factor/*metabolism
;
Disease Progression
;
Adenocarcinoma/drug therapy/enzymology
4.Rebamipide-induced downregulation of phospholipase D inhibits inflammation and proliferation in gastric cancer cells.
Dong Woo KANG ; Gyesik MIN ; Do Yoon PARK ; Ki Whan HONG ; Do Sik MIN
Experimental & Molecular Medicine 2010;42(8):555-564
Rebamipide a gastroprotective drug, is clinically used for the treatment of gastric ulcers and gastritis, but its actions on gastric cancer are not clearly understood. Phospholipase D (PLD) is overexpressed in various types of cancer tissues and has been implicated as a critical factor in inflammation and carcinogenesis. However, whether rebamipide is involved in the regulation of PLD in gastric cancer cells is not known. In this study, we showed that rebamipide significantly suppressed the expression of both PLD1 and PLD2 at a transcriptional level in AGS and MKN-1 gastric cancer cells. Downregulation of PLD expression by rebamipide inhibited its enzymatic activity. In addition, rebamipide inhibited the transactivation of nuclear factor kappa B (NFkappaB), which increased PLD1 expression. Rebamipide or PLD knockdown significantly suppressed the expression of genes involved in inflammation and proliferation and inhibited the proliferation of gastric cancer cells. In conclusion, rebamipide-induced downregulation of PLD may contribute to the inhibition of inflammation and proliferation in gastric cancer.
Alanine/*analogs & derivatives/pharmacology
;
Cell Line, Tumor
;
Cell Proliferation/drug effects
;
Down-Regulation/*drug effects
;
Gene Expression Regulation, Neoplastic/*drug effects
;
Humans
;
Inflammation/*enzymology/genetics/pathology
;
Isoenzymes/genetics/metabolism
;
NF-kappa B/metabolism
;
Phospholipase D/*genetics/metabolism
;
Promoter Regions, Genetic/genetics
;
Quinolones/*pharmacology
;
Stomach Neoplasms/*enzymology/genetics/*pathology
;
Transcription, Genetic/drug effects
5.Effect of lysyl oxidase on migration and adhesion of human gastric cancer HGC-27 cells in vitro.
Bai-jing MA ; Ling HUANG ; Mei HAN ; Yu-qiao WANG ; Jian-ning ZHAO ; Bo-jian SUN ; Jia-jing LIN ; Ting-ge SONG
Chinese Journal of Oncology 2011;33(5):331-333
OBJECTIVETo study the effects of lysyl oxidase (LOX) on the migration and adhesion of the human gastric cancer cell line HGC-27 cells in vitro.
METHODSThe human gastric cancer cell line HGC-27 cells were cultured in vitro, and treated with different concentration of β-aminopropionitrile (BAPN). The ability of migration was assessed by wound-healing assay. The ability of adhesion was detected by homogenous and heterogeneous adhesion experiments.
RESULTSCompared that with 0 mmol/L BAPN, the ability of migration of the cells after treatment with 0.2 mmol/L BAPN was descended at 8, 24, 32 and 48 h; the number of cells with homogeneous adhesion was increased from (6.97 ± 0.07) × 10(3)/ml to (7.78 ± 0.11) × 10(3)/ml; and the number of cells with heterogeneous adhesion was decreased from (8.98 ± 0.15) × 10(3)/ml to (8.35 ± 0.10) × 10(3)/ml, both < 0.05. Compared with that of cells treated with 0 mmol/L and 0.2 mmol/L BAPN, the migration ability of cells after treatment with 0.3 mmol/L BAPN was descended at 8, 24, 32 and 48 h; the number of cells with homogeneous adhesion was raised to (8.02 ± 0.11) × 10(3)/ml and the number of cells with heterogeneous adhesion was down to (7.93 ± 0.07) × 10(3)/ml (P < 0.05).
CONCLUSIONLOX may promote the metastasis of cancer cells by enhancing invasion, increasing heterogeneous adhesion and decreasing homogeneous adhesion.
Aminopropionitrile ; administration & dosage ; pharmacology ; Cell Adhesion ; drug effects ; Cell Line, Tumor ; Cell Movement ; drug effects ; Dose-Response Relationship, Drug ; Humans ; Neoplasm Invasiveness ; Protein-Lysine 6-Oxidase ; antagonists & inhibitors ; metabolism ; physiology ; Stomach Neoplasms ; enzymology ; pathology
6.Study of growth inhibition of gastric cancer cells by sRNA targeting polo like kinase 1 in vitro and vivo.
Bin LAN ; Bing-ya LIU ; Xue-hua CHENG ; Ying QU ; Xiao-qing ZHANG ; Qu CAI ; Qi-bao DAI ; Zheng-Gang ZHU
Chinese Journal of Surgery 2006;44(1):40-44
OBJECTIVETo observe the effect of polo like kinase 1 (plk1) gene depletion on the growth of gastric cancer cell line-MKN45 cells in vitro and vivo and discuss the feasibility and effectiveness of arranging plk1 as gene therapeutic target for gastric cancer.
METHODSThe plk1 expression of MKN45 cells was inhibited by RNA interference (RNAi). The plk1 mRNA and protein level were measured by real-time quantitative PCR and western blotting, and the change of cell cycle distribution and apoptosis rate were detected by flow-cytometry, and the MKN45 cells proliferation was measured by MTT method. MKN45 cells treated with plk1 siRNA were transplanted subcutaneously in nude mice and their tumorgenesis ability were observed, the plk1 protein levels of the samples from nude mice in different groups were compared.
RESULTSAfter treatment with plk1 siRNA, plk1 mRNA and protein level decreased obviously in certain time, more MKN45 cells accumulated at G(2)/M (P < 0.05). Apoptosis rate of MKN45 cells treated with plk1 siRNA was higher than that of control cells at 48 h and 72 h (P < 0.05), and MKN45 cells proliferated slowly than control groups (P < 0.05), while the tumorgenesis ability obviously decreased, but the plk1 protein levels of the samples from nude mice in different groups were not different.
CONCLUSIONSsiRNA targeting plk1 can inhibit the proliferation of MKN45 cells in vitro and vivo. Plk1 may be a novel therapeutic target for gastric cancer.
Animals ; Apoptosis ; drug effects ; Cell Cycle Proteins ; drug effects ; genetics ; Cell Line, Tumor ; Cell Proliferation ; drug effects ; Male ; Mice ; Mice, Nude ; Protein-Serine-Threonine Kinases ; drug effects ; genetics ; Proto-Oncogene Proteins ; drug effects ; genetics ; RNA Interference ; RNA, Small Interfering ; genetics ; pharmacology ; Stomach Neoplasms ; drug therapy ; enzymology ; pathology ; Transfection
7.Therapeutic effect of cisapride on gastric injury following hemorrhagic shock resuscitation in rats.
Lian-yang ZHANG ; Zheng-guo WANG ; Pei-fang ZHU ; Yan XU
Chinese Journal of Traumatology 2005;8(2):101-104
OBJECTIVETo investigate the therapeutic effect of cisapride on gastric injury following hemorrhagic shock resuscitation.
METHODS108 Wistar rats weighing (200 g+/-30 g) were randomly divided into a sham shock (SS) group (n=36), a hemorrhagic shock resuscitation (HS) group (n=36) and a hemorrhagic shock cisapride treated (HSC) group (n=36). Sampling at 1, 2 and 4 hours after resuscitation was done and 6 samples for each observation item were taken. The gastric blood flow volume was measured by isotope label biological microglobulin. Gastric pHi, gastric emptying, MDA and Na+-K+-ATPase of gastric mucosa were measured.
RESULTSIn the HSC group, the relative residual rate of gastric pigment decreased significantly, the gastric blood flow volume elevated; gastric pHi increased significantly at 2 hours; the level of mucosal MDA decreased at 4 hours, the activity of Na+-K+-ATPase increased and the lactic acid level in the portal vein decreased significantly compared to the HS group.
CONCLUSIONSAfter hemorrhagic shock resuscitation, cisapride contained the following functions, 1) promoting gastric emptying, 2) increasing the blood flow of gastric blood flow volume and gastric pHi, 3) depressing the lactic acid concentration of the portal vein and improving MDA volume and Na+-K+-ATPase activity of gastric mucosa. It suggests that after complementing effective circulating blood volume for hemorrhagic shock resuscitation, early use of cisapride for gastric motility is helpful for an improvement of lasting ischemia and hypoxia in stomach.
Animals ; Cisapride ; therapeutic use ; Disease Models, Animal ; Gastric Emptying ; drug effects ; Gastric Mucosa ; chemistry ; enzymology ; Gastrointestinal Agents ; therapeutic use ; Hydrogen-Ion Concentration ; drug effects ; Rats ; Rats, Wistar ; Regional Blood Flow ; drug effects ; Resuscitation ; Shock, Hemorrhagic ; complications ; therapy ; Sodium-Potassium-Exchanging ATPase ; metabolism ; Stomach ; blood supply ; pathology ; Stomach Diseases ; drug therapy ; etiology
8.Anti-proliferative and apoptotic effects of S1, a tetrandrine derivative, in human gastric cancer BGC-823 cells.
Rong-Rong LEI ; Hai-Feng HU ; Fan BAI ; Ying LIU ; Chun-Zhen WU ; Xiao-Xing HUANG ; Li-Ping XIE ; You-Jia HU
Chinese Journal of Natural Medicines (English Ed.) 2016;14(7):527-533
The aim of the study was to investigate the anti-proliferation and apoptosis-inducing effects of S1, a novel tetrandrine derivative, in human gastric cancer BGC-823 cells and explore the possible mechanism of action. The anti-proliferative activity was determined by MTT assay; the induction of cell cycle arrest and apoptosis were detected by flow cytometry. Quantitative real time RT-PCR and Western blotting were used to evaluate the mRNA and protein expression levels in mitochondrial pathway. S1 significantly reduced cell viability and induced a G2/M phase arrest and apoptosis in dose- and time-dependent manner. Further studies showed that S1 increased mRNA and protein expression of Bax and the Bax/Bcl-2 ratio. Moreover, S1 decreased the protein expression of procaspase-9 and procaspase-3, suggesting that the induction of apoptosis may be related to the alteration of the ratio of Bax/Bcl-2 and the activation of caspases. These findings suggested that S1 merits further investigation as a novel therapeutic agent for the treatment of human gastric cancer.
Antineoplastic Agents
;
pharmacology
;
Apoptosis
;
drug effects
;
Benzylisoquinolines
;
chemistry
;
pharmacology
;
Caspase 3
;
genetics
;
metabolism
;
Caspase 9
;
genetics
;
metabolism
;
Cell Cycle Checkpoints
;
drug effects
;
Cell Line, Tumor
;
Cell Proliferation
;
drug effects
;
Cell Survival
;
drug effects
;
Humans
;
Proto-Oncogene Proteins c-bcl-2
;
genetics
;
metabolism
;
Stomach Neoplasms
;
drug therapy
;
enzymology
;
genetics
;
physiopathology
;
bcl-2-Associated X Protein
;
genetics
;
metabolism
9.Nimesulide, a selective cyclooxygenase-2 inhibitor inhibits telomerase activity by blocking activation of PKB in gastric cancer cell line.
Guo-yong HU ; Bao-ping YU ; Jie-ping YU ; Zong-xue RAN ; He-sheng LUO
Chinese Journal of Oncology 2004;26(4):209-212
OBJECTIVETo study the effects of nimesulide, a selective COX-2 inhibitor, on cell viability, telomerase and PKB activities in human gastric cancer cell line SGC7901 and to explore its molecular mechanism of selective growth inhibition.
METHODSMTT assay was used to determine cell viability after incubation for 0, 12, 24, and 48 h in different concentrations (0, 25, 50, 100, 200 micro mol/L) of nimesulide and/or okadaic acid (300 nmol/L). Telomerase and protein kinase B (PKB) activities were detected using TRAP PCR-ELISA and nonradioactive IP-kinase assay.
RESULTSNimsulide caused a time and dose-dependent reduction of cell numbers of SGC7901. The telomerase and PKB activities were significantly inhibited, and the inhibition of telomerase activity was partly associated with decrease in PKB activity.
CONCLUSIONSelective COX-2 inhibitor nimesulide inhibits telomerase activity of gastric cancer cells by partly blocking the activation of protein kinase B. The results suggest an additional signaling pathway underlying the anti-cancer effect of COX-2 inhibitor.
Adenocarcinoma ; enzymology ; pathology ; Cell Line, Tumor ; Cell Proliferation ; drug effects ; Cyclooxygenase Inhibitors ; pharmacology ; Dose-Response Relationship, Drug ; Enzyme Activation ; drug effects ; Humans ; Protein-Serine-Threonine Kinases ; metabolism ; Proto-Oncogene Proteins ; metabolism ; Proto-Oncogene Proteins c-akt ; Stomach Neoplasms ; enzymology ; pathology ; Sulfonamides ; pharmacology ; Telomerase ; metabolism ; Time Factors
10.Mitosis arrest caused by inhibition of PLK1 expression in gastric cancer MKN45 cells.
Bin LAN ; Bing-ya LIU ; Xue-hua CHEN ; Ying QU ; Xiao-qing ZHANG ; Qu CAI ; Qi-bao DAI ; Zheng-gang ZHU
Chinese Journal of Oncology 2006;28(3):164-168
OBJECTIVETo observe the effect of polo-like kinase 1 (PLK1) gene depletion on mitosis phenotype and elucidate its vital role in gastric cancer cell line (MKN45) mitosis.
METHODSThe PLK1 expression in MKN45 cells was blocked by RNA interference (RNAi), the expression level of PLK1 mRNA and protein were measured by real-time quantitative PCR and Western blot, respectively. The morphological change of microtubules and mitosis phenotype in MKN45 cells were observed by immunofluorescence staining and laser confocal microscopy, the morphological changes of cells were observed by reverse microscopy, the variation of cell cycle distribution was detected by flow-cytometry.
RESULTSAfter RNAi targeting PLK1, PLK1 mRNA and protein level decreased obviously, the cell microtubules became obscure and lost cohesiveness, the mitosis phenotype also varied substantially (P < 0.05), more gastric cancer cells became rounded and showed G(2) phase cell DNA content (P < 0.05).
CONCLUSIONPLK1 gene plays a key role in mitosis and its inhibition can lead to mitosis arrest in MKN45 cells.
Adenocarcinoma ; enzymology ; metabolism ; pathology ; Cell Cycle Proteins ; biosynthesis ; genetics ; Cell Line, Tumor ; G2 Phase ; drug effects ; Humans ; Mitosis ; drug effects ; Protein-Serine-Threonine Kinases ; biosynthesis ; genetics ; Proto-Oncogene Proteins ; biosynthesis ; genetics ; RNA Interference ; RNA, Messenger ; biosynthesis ; genetics ; RNA, Small Interfering ; genetics ; pharmacology ; Stomach Neoplasms ; enzymology ; metabolism ; pathology ; Transfection